Portal Biotechnologies
Arlington, US · Founded 2022 · Delaware corporation · 5 known investors
Biotech
Founders & leadership
AS
Armon ShareiExecutive Officer, Director
Investors · 5
Reported raises · per SEC filings
Form D private placements▶$9MraisedMay 2026 · 12 investors · BiotechnologyRule 506(b)
▶$9MraisedMay 2026 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Armon ShareiExecutive Officer, Director
- Offering amount
- $9M
- Amount sold
- $9M
- Minimum investment
- $30K
- First sale
- May 2026
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$11.7MraisedMay 2026 · 43 investors · BiotechnologyRule 506(b)
▶$11.7MraisedMay 2026 · 43 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Armon ShareiExecutive Officer, Director
- Alec BarlcayExecutive Officer, Director
- Offering amount
- $11.9M
- Amount sold
- $11.7M
- Minimum investment
- $10K
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Portal Biotechnologies Raises $9M in Fundingfinsmes.com · 2026
- Portal Biotechnologies Accelerates Growth with Latest Round Led by NFX, Expanded DARPA Contract, and Broad Adoption Across Top Pharma and Academic Centersbusinesswire.com · 2026
- Portal Biotechnologies Raises $9 Million to Scale Cell Engineering Platform | citybizcitybiz.co · 2026

